INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 273 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,841,734 | -27.9% | 545,738 | -22.3% | 0.01% | -25.0% |
| Q2 2023 | $28,891,357 | -36.4% | 702,440 | -11.2% | 0.01% | -42.9% |
| Q1 2023 | $45,394,948 | +9.4% | 790,715 | +6.9% | 0.01% | +7.7% |
| Q4 2022 | $41,490,006 | +46.4% | 739,968 | +10.6% | 0.01% | +30.0% |
| Q3 2022 | $28,333,000 | -20.4% | 668,843 | +1.5% | 0.01% | -16.7% |
| Q2 2022 | $35,610,000 | -15.9% | 659,066 | +0.0% | 0.01% | -7.7% |
| Q1 2022 | $42,343,000 | -0.5% | 658,928 | +3.7% | 0.01% | 0.0% |
| Q4 2021 | $42,551,000 | +0.8% | 635,177 | +3.0% | 0.01% | -7.1% |
| Q3 2021 | $42,227,000 | +5.5% | 616,623 | +5.1% | 0.01% | +7.7% |
| Q2 2021 | $40,021,000 | +2.2% | 586,469 | +3.5% | 0.01% | -7.1% |
| Q1 2021 | $39,148,000 | +9.2% | 566,621 | +2.6% | 0.01% | 0.0% |
| Q4 2020 | $35,856,000 | +37.2% | 552,304 | -0.2% | 0.01% | +16.7% |
| Q3 2020 | $26,137,000 | +0.5% | 553,500 | +0.0% | 0.01% | -7.7% |
| Q2 2020 | $26,004,000 | +5.2% | 553,381 | +0.0% | 0.01% | -13.3% |
| Q1 2020 | $24,719,000 | -23.0% | 553,348 | +0.4% | 0.02% | -11.8% |
| Q4 2019 | $32,109,000 | -1.8% | 550,934 | +1.2% | 0.02% | -10.5% |
| Q3 2019 | $32,692,000 | +19.6% | 544,230 | +11.2% | 0.02% | +11.8% |
| Q2 2019 | $27,344,000 | +3.0% | 489,590 | +2.8% | 0.02% | 0.0% |
| Q1 2019 | $26,545,000 | +32.6% | 476,398 | +7.3% | 0.02% | +13.3% |
| Q4 2018 | $20,016,000 | -31.4% | 443,800 | +0.2% | 0.02% | -21.1% |
| Q3 2018 | $29,166,000 | +49.3% | 442,777 | +46.0% | 0.02% | +35.7% |
| Q2 2018 | $19,532,000 | -3.9% | 303,231 | -17.4% | 0.01% | -12.5% |
| Q1 2018 | $20,324,000 | +31.2% | 367,252 | +13.5% | 0.02% | +33.3% |
| Q4 2017 | $15,488,000 | +4.4% | 323,610 | +10.2% | 0.01% | -7.7% |
| Q3 2017 | $14,830,000 | +0.9% | 293,774 | +9.0% | 0.01% | -7.1% |
| Q2 2017 | $14,694,000 | +42.4% | 269,556 | +10.0% | 0.01% | +40.0% |
| Q1 2017 | $10,322,000 | +6.5% | 244,982 | +116.8% | 0.01% | -9.1% |
| Q4 2016 | $9,694,000 | +11.2% | 112,987 | +7.0% | 0.01% | +10.0% |
| Q3 2016 | $8,718,000 | -25.9% | 105,602 | -28.4% | 0.01% | -33.3% |
| Q2 2016 | $11,772,000 | +10.5% | 147,545 | -6.7% | 0.02% | +7.1% |
| Q1 2016 | $10,653,000 | +1.7% | 158,137 | +2.4% | 0.01% | 0.0% |
| Q4 2015 | $10,473,000 | +10.7% | 154,503 | -2.7% | 0.01% | 0.0% |
| Q3 2015 | $9,460,000 | +31.6% | 158,857 | +48.9% | 0.01% | +40.0% |
| Q2 2015 | $7,187,000 | +13.4% | 106,666 | +3.7% | 0.01% | +11.1% |
| Q1 2015 | $6,340,000 | +20.7% | 102,829 | +6.2% | 0.01% | +12.5% |
| Q4 2014 | $5,252,000 | +12.4% | 96,832 | +2.9% | 0.01% | 0.0% |
| Q3 2014 | $4,672,000 | +24.5% | 94,113 | +18.0% | 0.01% | +33.3% |
| Q2 2014 | $3,753,000 | +9.1% | 79,741 | +6.6% | 0.01% | 0.0% |
| Q1 2014 | $3,439,000 | +1.7% | 74,776 | +5.5% | 0.01% | 0.0% |
| Q4 2013 | $3,383,000 | +39.1% | 70,898 | +19.5% | 0.01% | +20.0% |
| Q3 2013 | $2,432,000 | +6.4% | 59,307 | -4.8% | 0.01% | 0.0% |
| Q2 2013 | $2,286,000 | – | 62,272 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
| Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
| Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
| KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
| Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
| Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
| Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
| COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |